Search
for
Sort by
Research 91–120 of 1000+
- Assisted reproductive outcomes in women with different polycystic ovary syndrome phenotypes
- Skin manifestations of hyperandrogenism: an update
- Genetic, hormonal and metabolic aspects of PCOS: an update
- Polycystic Ovary Syndrome, Insulin Resistance, and Obesity: Navigating the Pathophysiologic Labyrinth
- The pathophysiology of polycystic ovary syndrome: trying to understand PCOS and its endocrinology
- The Role of Oral Contraceptives in the Treatment of Hyperandrogenic Disorders
- Differential Expression of miR-93 and miR-21 in Granulosa Cells and Follicular Fluid of Polycystic Ovary Syndrome Associating with Different Phenotypes
- Regenerative Effect of Intraovarian Injection of Activated Autologous Platelet Rich Plasma: Serum Anti-Mullerian Hormone Levels Measured Among Poor-Prognosis In Vitro Fertilization Patients
- Women's midlife health Reframing menopause
- Expression of AKT1 along with AKT2 in granulosa-lutein cells of hyperandrogenic PCOS patients
- Genetic basis of polycystic ovary syndrome
- Alopecia and Hirsuties
- Treatment of androgen excess in females: Yesterday, today and tomorrow
- Pharmacological Options for Treatment of Hyperandrogenic Disorders
- Infertility: Evaluation and Initial Management
- INCIDENCE OF VIRILISATION IN SEX CORD STROMAL TUMOURS OF OVARY, A 5- YEAR EXPERIENCE IN A TERTIARY CARE GYNAECOLOGICAL CENTRE
- A review on PCOS: Its causes, symptoms, pathogenesis and management
- Clinical Utility of GnRH Analogues in Female Androgen Excess: Highlighting Diagnostic and Therapeutic Applications
- A Systematic Review of the Potential Role of Cinnamomum spp. in Modulating Insulin Sensitivity and Hyperandrogenism in Polycystic Ovary Syndrome (PCOS)
- DHEA and TNF-α: Key Factors in Managing Polycystic Ovary Syndrome in Iraqi Females
- Mini Review on Polycystic Ovary Syndrome (PCOS)
- POLYCYSTIC OVARY SYNDROME (PCOS)–AN OVERVIEW
- Syndromes of Severe Insulin Resistance (SSIRs)
- Secondary amenorrhea
- Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome
- Sex Hormone-Binding Globulin (SHBG) as an Early Biomarker and Therapeutic Target in Polycystic Ovary Syndrome
- Clinico-investigative profile of patients of hirsutism in a tertiary level institution
- A study on the clinical and hormonal profile of patients with hirsutism
- Role of plasminogen activator inhibitor type 1 (PAI-1) in PCOS patient
- Management of Hirsutism and Acne in Women with Polycystic Ovary Syndrome: A Narrative Review of Current Evidence and Emerging Therapies